NASDAQ (usa) arrow 6715.56 -12.11 -0.18%
FTSE 100 (london) arrow 7487.96 -5.12 -0.07%
DAX (german) arrow 13465.51 235.94 1.78%
NIKKEI 225 (japan) arrow 22420.08 408.47 1.86%
Hang - Seng (hong kong) arrow 28594.06 348.52 1.23%
NIFTY - 50 (india)
Straits Times (singapore) arrow 3391.61 17.53 0.52%
KOSPI (korea) arrow 2556.47 33.04 1.31%
All Ordinaries (australia) arrow 6005.30 28.90 0.48%
BOVESPA (brazil) arrow 74092.76 -215.73 -0.29%

Zealand Pharma A/S (PINK: ZLDPF)

 
ZLDPF Technical Analysis
1.5
As on 31st Oct 2025 ZLDPF STOCK Price closed @ 79.15 and we RECOMMEND Sell for LONG-TERM with Stoploss of 101.24 & Buy for SHORT-TERM with Stoploss of 68.24 we also expect STOCK to react on Following IMPORTANT LEVELS.
 
 

ZLDPFSTOCK Price

Open 79.15 Change Price %
High 79.15 1 Day 9.15 13.07
Low 79.15 1 Week -0.05 -0.06
Close 79.15 1 Month 28.90 57.51
Volume 207 1 Year 27.25 52.50
52 Week High 141.74 | 52 Week Low 50.14
 
PINK USA Most Active Stocks
UMAV 0.00 %
DPLS 0.00 %
AFFU 0.00 %
BCDS 0.00 %
TXGE 3316.21 2.69%
GTVH 0.00 %
OZSC 0.00 %
TWOH 0.00 %
LTNC 0.00 %
RMRK 0.00 %
 
PINK USA Top Gainers Stocks
ANAV 12.05 30025.00%
WINSF 0.69 6800.00%
CGGYY 41.88 6765.57%
BKGM 950.00 6566.67%
NWPIF 0.98 4800.00%
GPGC 0.40 3900.00%
IHRTB 2.49 2390.00%
NFGRF 0.11 1000.00%
NZERD 0.36 800.00%
LOGQ 0.49 716.67%
 
PINK USA Top Losers Stocks
ZUUS 0.00 -100.00%
XSVT 0.00 -100.00%
VYEY 0.00 -100.00%
VIDE 0.00 -100.00%
STMGF 0.00 -100.00%
STHFF 0.00 -100.00%
SPGX 0.00 -100.00%
SVLT 0.00 -100.00%
SKLV 0.06 -100.00%
SKLV 0.06 -100.00%
 
 
ZLDPF
Daily Charts
ZLDPF
Intraday Charts
Whats New @
Bazaartrend
ZLDPF
Free Analysis
 
ZLDPF Important Levels Intraday
RESISTANCE79.15
RESISTANCE79.15
RESISTANCE79.15
RESISTANCE79.15
RESISTANCE79.15
RESISTANCE79.15
RESISTANCE79.15
RESISTANCE79.15
 
ZLDPF Forecast November 2025
4th UP Forecast117.61
3rd UP Forecast105.28
2nd UP Forecast97.65
1st UP Forecast90.03
1st DOWN Forecast68.27
2nd DOWN Forecast60.65
3rd DOWN Forecast53.02
4th DOWN Forecast40.69
 
ZLDPF Weekly Forecast
4th UP Forecast92.02
3rd UP Forecast87.89
2nd UP Forecast85.34
1st UP Forecast82.79
1st DOWN Forecast75.51
2nd DOWN Forecast72.96
3rd DOWN Forecast70.41
4th DOWN Forecast66.28
 
ZLDPF Forecast2025
4th UP Forecast255.66
3rd UP Forecast199.05
2nd UP Forecast164.06
1st UP Forecast129.07
1st DOWN Forecast29.23
2nd DOWN Forecast-5.76
3rd DOWN Forecast-40.75
4th DOWN Forecast-97.36
 
 
ZLDPF Other Details
Segment EQ
Market Capital 1372448384.00
Sector Healthcare
Industry Biotechnology
Offical website >
 
ZLDPF Address
ZLDPF
 
ZLDPF Latest News
 
Your Comments and Response on Zealand Pharma A/S
 
ZLDPF Business Profile
Zealand Pharma A/S, a biotechnology company, engages in the discovery, design, and development of peptide-based medicines in Denmark. It has a portfolio of medicines focusing on gastrointestinal and metabolic diseases, and other specialty disease areas with unmet medical needs. The company markets lixisenatide under the brand names of Adlyxin, Lyxumia, Soliqua 100/33, and Suliqua. Its product pipeline includes Dasiglucagon single use syringe or autoinjector that has completed Phase III clinical trials for the treatment of severe hypoglycemia; Dasiglucagon dual-hormone artificial pancreas has completed Phase II clinical trials for automated diabetes management; Dasiglucagon that is in Phase III clinical trials for congenital hyperinsulinism and in Phase II clinical trials for post bariatric surgery hypoglycemia. The company is also developing glepaglutide, a long acting GLP-2 analog, which is in Phase III clinical trials for the treatment of short bowel syndrome. Zealand Pharma A/S has collaboration agreements with Sanofi-Aventis Deutschland GmbH; Boehringer Ingelheim International GmbH; Alexion; and Beta Bionics, Inc. The company was founded in 1997 and is headquartered in Copenhagen, Denmark. Address: Sydmarken 11, Copenhagen, Denmark, 2860
 
© 2005-2023 BazaarTrend.com All rights reserved.

Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service